DK127676B - Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer. - Google Patents

Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer.

Info

Publication number
DK127676B
DK127676B DK317070AA DK317070A DK127676B DK 127676 B DK127676 B DK 127676B DK 317070A A DK317070A A DK 317070AA DK 317070 A DK317070 A DK 317070A DK 127676 B DK127676 B DK 127676B
Authority
DK
Denmark
Prior art keywords
preparation
complex containing
coagulation factors
prothrombin complex
containing coagulation
Prior art date
Application number
DK317070AA
Other languages
Danish (da)
English (en)
Inventor
L Fekete
E Shanbrom
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of DK127676B publication Critical patent/DK127676B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK317070AA 1969-06-19 1970-06-19 Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer. DK127676B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83488369A 1969-06-19 1969-06-19

Publications (1)

Publication Number Publication Date
DK127676B true DK127676B (da) 1973-12-17

Family

ID=25268043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK317070AA DK127676B (da) 1969-06-19 1970-06-19 Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer.

Country Status (13)

Country Link
US (1) US3560475A (fr)
BE (1) BE751667A (fr)
CA (1) CA920058A (fr)
DE (1) DE2029455C3 (fr)
DK (1) DK127676B (fr)
ES (1) ES380950A1 (fr)
FR (1) FR2052987B1 (fr)
GB (1) GB1253339A (fr)
IL (1) IL34599A (fr)
IT (1) IT1043810B (fr)
NL (1) NL170150C (fr)
SE (1) SE397474B (fr)
ZA (1) ZA703574B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4046877A (en) * 1975-07-18 1977-09-06 Syntex (U.S.A.) Inc. Method of increasing immunologic competence
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
WO1981002105A1 (fr) * 1980-01-28 1981-08-06 Baxter Travenol Lab Compositions therapeutiques et procede de fabrication et d'utilisation de celles-ci
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
USRE38431E1 (en) * 1995-12-01 2004-02-17 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6320029B1 (en) 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
JP3944267B2 (ja) * 1996-08-09 2007-07-11 財団法人化学及血清療法研究所 プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
US5770705A (en) * 1996-11-01 1998-06-23 Shanbrom Technologies Llc Method for recovering proteins from plasma using insoluble, water-absorbing material
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
WO2005094873A1 (fr) 2004-03-19 2005-10-13 Baxter International Inc. Facteur ixa pour le traitement de troubles de saignement
WO2022064478A1 (fr) 2020-09-23 2022-03-31 Omrix Biopharmaceuticals Ltd. Formulations hémostatiques et leurs utilisations

Also Published As

Publication number Publication date
ES380950A1 (es) 1972-10-16
BE751667A (fr) 1970-11-16
IT1043810B (it) 1980-02-29
NL170150C (nl) 1982-10-01
NL170150B (nl) 1982-05-03
FR2052987B1 (fr) 1974-05-24
SE397474B (sv) 1977-11-07
IL34599A0 (en) 1970-07-19
CA920058A (en) 1973-01-30
NL7008957A (fr) 1970-12-22
US3560475A (en) 1971-02-02
GB1253339A (en) 1971-11-10
DE2029455A1 (de) 1971-02-25
DE2029455C3 (de) 1979-04-19
IL34599A (en) 1973-07-30
DE2029455B2 (de) 1978-08-24
ZA703574B (en) 1971-01-27
FR2052987A1 (fr) 1971-04-16

Similar Documents

Publication Publication Date Title
DK127676B (da) Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer.
DK130018B (da) Fremgangsmåde til fremstilling af L-lysin.
DK130306B (da) Analogifremgangsmåde til fremstilling af S-trialkylphosphinguld-1-thio-β-D-glucopyranosider.
DK136314B (da) Analogifremgangsmåde til fremstilling af benzamidoethylpiperaziner.
DK137167B (da) Fremgangsmåde til fremstilling af et stabilt skumdæmpende middel.
DK135760B (da) Fremgangsmåde til fremstilling af vanadiumforbindelser.
DK140697B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin.
DK124195B (da) Fremgangsmåde til fremstilling af cis-chrysantheminsyrer.
DK133375B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-phenylpyrrolidiner.
DK130576B (da) Fremgangsmåde til fremstilling af et formgivet katalysatormateriale.
DK128006B (da) Analogifremgangsmåde til fremstilling af 11-desacetoxy-wortmannin.
DK122105B (da) Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer.
DK128737B (da) Analogifremgangsmåde til fremstilling af 6α-methyl-17α-caproyloxy-19-norprogesteron.
DK125199B (da) Analogifremgangsmåde til fremstilling af benzamidiner.
DK129045B (da) Analogifremgangsmåde til fremstilling af (p-fluorpheny)-pyridincarboxylsyrer.
DK122456B (da) Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd.
DK122127B (da) Analogifremgangsmåde til fremstilling af 3-phenyl-4-acyloxycarbostyriler.
DK123816B (da) Analogifremgangsmåde til fremstilling af N-phenacylcarbamater.
DK124686B (da) Analogifremgangsmåde til fremstilling af bis-thiachromonylforbindelser.
DK139071B (da) Fremgangsmåde til fremstilling af copolymerisater.
DK126660B (da) Fremgangsmåde til fremstilling af et vanduopløseligt enzympræparat.
DK123527B (da) Fremgangsmåde til fremstilling af lumilysergsyrederivater.
DK132026B (da) Fremgangsmåde til fremstilling af 6-aminoacylamidopenicillansyrer.
DK124478B (da) Fremgangsmåde til fremstilling af triklormetantiosulfenylklorid.
DK125918B (da) Fremgangsmåde til fremstilling af alkyl-7-0-methyl-l-thio-lincosaminider.